Literature DB >> 14594048

[The initial prodrome in schizophrenia--core dimensions of experience and behavior].

Paul Møller1, Ragnhild Husby.   

Abstract

BACKGROUND: In order to identify and possibly prevent psychosis at prodromal stages, it is important to learn how patients and families perceive initial prodromes, particularly the prodromal subjective experiences.
MATERIALS AND METHODS: We explore prodromal phenomena and identify potential core dimensions in 19 first-episode DSM-IV schizophrenia patients and describe experiences and behaviour that appear to be essential components of initial prodromes. RESULTS AND
INTERPRETATION: The subjects reported serious difficulties interpreting and talking about prodromal experiences at the time when they occurred; this caused delayed identification, the reasons for which we report. Out of eight groups of prodromal experiences we highlight two as tentative core dimensions: [disturbance of perception of self] and [extreme preoccupation by and withdrawal to overvalued ideas]. Four potential dimensions of prodromal behaviour are also identified: (1) leaving school, university or job, or major school truancy, (2) marked and lasting observable shift of interests, (3) marked and lasting social passivity, withdrawal, or isolation, and (4) marked and lasting change in global appearance or behaviour.

Entities:  

Mesh:

Year:  2003        PMID: 14594048

Source DB:  PubMed          Journal:  Tidsskr Nor Laegeforen        ISSN: 0029-2001


  3 in total

Review 1.  Eating disorders and psychosis: Seven hypotheses.

Authors:  Mary V Seeman
Journal:  World J Psychiatry       Date:  2014-12-22

2.  Aripiprazole Long-Acting Injection During First Episode Schizophrenia-An Exploratory Analysis.

Authors:  Gloria Giordano; Lorenzo Tomassini; Ilaria Cuomo; Emanuela Amici; Filippo Perrini; Gemma Callovini; Alfonso Carannante; Georgios D Kotzalidis; Sergio De Filippis
Journal:  Front Psychiatry       Date:  2020-01-08       Impact factor: 4.157

Review 3.  Pivotal mental states.

Authors:  Ari Brouwer; Robin Lester Carhart-Harris
Journal:  J Psychopharmacol       Date:  2020-11-11       Impact factor: 4.153

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.